Duration of anticoagulant therapy in venous thromboembolism
24 results
1 - 24
Duration of anticoagulant therapy in venous thromboembolism - Warfarin therapy
- Deep vein thrombosis
Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair- Antithrombotic agents in primary health care
- Prevention of venous thromboembolism
- Warfarin initiation nomograms for venous thromboembolism: Cochrane systematic review
- Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia
Anticoagulant therapy for 6 weeks is noninferior to 3 months for provoked VTE in patients younger than 21 years (Kids-DOTT)- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Rivaroxaban effective for acute DVT (EINSTEIN)
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis
- Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism
- Treatment of distal deep vein thrombosis
- Oral rivaroxaban as effective as standard therapy for treatment of acute PE
- Idraparinux effective for DVT but not for PE
- Antithrombotic treatment after stroke due to intracerebral haemorrhage
- COVID-19 and other coronavirus infections